Investigating ELOVL7 coding variants in multiple system atrophy

Anna I. Wernick, Ronald L. Walton, Alexandra I. Soto-Beasley, Shunsuke Koga, Yingxue Ren, Michael G. Heckman, Lukasz M. Milanowski, Rebecca R. Valentino, Naveen Kondru, Ryan J. Uitti, William P. Cheshire, Zbigniew K. Wszolek, Dennis W. Dickson, Owen A. Ross

Research output: Contribution to journalArticlepeer-review


Multiple system atrophy (MSA) is a rare sporadic, progressive parkinsonism characterised by autonomic dysfunction. A recent genome-wide association study reported an association at the Elongation of Very Long Fatty Acids Protein 7 (ELOVL7) locus with MSA risk. In the current study four independent and unrelated cohorts were assessed, consisting of pathologically confirmed MSA cases, Parkinson's disease (PD) cases, and two unrelated, healthy control groups. All exons of ELOVL7 were sequenced in pathologically confirmed MSA cases; data for PPMI samples and Biobank controls was extracted from whole genome sequence. Coding variants in ELOVL7 were extremely rare, and we observed no significant association of ELOVL7 coding variants with risk of MSA.

Original languageEnglish (US)
Article number135723
JournalNeuroscience Letters
StatePublished - Apr 1 2021


  • ELOVL7
  • Genetics
  • Lipids
  • Multiple system atrophy
  • Synucleinopathy

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Investigating ELOVL7 coding variants in multiple system atrophy'. Together they form a unique fingerprint.

Cite this